YZJ-1139 20mg

DRUG2 trials

Sponsors

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Conditions

Insomnia Disorder

Phase 2

Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder

CompletedNCT06680505

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.Insomnia Disorder

Start: 2019-08-04End: 2021-03-29Updated: 2024-11-08

Phase 3

Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder

CompletedNCT05525637

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.Insomnia Disorder

Start: 2021-12-17End: 2023-09-27Updated: 2026-06-30